Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • TISSUE  (3)
  • 1
    Keywords: measurement ; ANGIOGENESIS ; Germany ; PERFUSION ; CLASSIFICATION ; CT ; imaging ; INFORMATION ; QUANTIFICATION ; liver ; TISSUE ; TUMORS ; computed tomography ; PATIENT ; BLOOD-FLOW ; INDEX ; primary ; INJECTION ; SIGNAL ; LESIONS ; PATTERNS ; DIFFERENCE ; metastases ; US ; tomography ; COMPUTED-TOMOGRAPHY ; LIVER METASTASES ; POWER DOPPLER SONOGRAPHY ; VASCULARIZATION ; contrast-enhanced ultrasound,liver metastases,arterial perfusion,low-MI imaging,SonoVue ; MICROBUBBLE CONTRAST ; SHU 508A
    Abstract: Rationale and Objectives: We investigated whether observing the arterial vascularization of liver metastases by contrast-enhanced ultrasound with low mechanical index (low-MI) imaging offers additional diagnostic information for the characterization of the liver lesions.Methods: Twenty nine patients with untreated liver metastases of different primaries were examined. Measurements were performed using a low frame rate, low-MI pulse inversion technique after injection of 2.4 mL SonoVue. The relative maximum signal intensity of the liver lesions related to the normal liver tissue was quantified. Ultrasound findings were compared with contrast-enhanced, dual-phase computed tomography (CT) using a pattern-based classification scheme.Results: Compared with contrast-enhanced CT, this modality better detects arterial perfusion. Metastases, even those usually considered hypovascularized, often showed homogeneous enhancement (66%) and higher arterial vascularization than normal liver tissue. CT did not show a comparable vascularization pattern (P 〈 0.001) or any similarly early signal intensity (P 〈 0.001).Conclusions: Contrast-enhanced CT may not be able to visualize short-lasting but large differences of the arterial perfusion of liver metastases, as does contrast-enhanced low-MI ultrasound. This offers new methods for their characterization and for monitoring of therapeutic effects
    Type of Publication: Journal article published
    PubMed ID: 15021325
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: tumor ; AGENTS ; BLOOD ; Germany ; IN-VIVO ; MODEL ; PERFUSION ; THERAPY ; VIVO ; imaging ; QUANTIFICATION ; VOLUME ; liver ; TISSUE ; TIME ; BLOOD-FLOW ; INDEX ; CONTRAST ; blood flow ; CONTRAST AGENT ; FLOW ; INJECTION ; BIOLOGY ; metastases ; US ; PARAMETERS ; tomography ; KINETICS ; LIVER METASTASES ; CONTRAST AGENTS ; POWER DOPPLER SONOGRAPHY ; INDUCED DESTRUCTION ; AGENT ; TRANSIT-TIME ; DESTRUCTION ; REAL-TIME ; tissue viability ; OCT ; ENHANCED SONOGRAPHY ; HEPATIC METASTASES ; HEPATIC PERFUSION ; low-MI ultrasound ; MATHEMATICAL-MODEL ; quantification of perfusion ; replenishment kinetics ; TUMOR PERFUSION ; ultrasound contrast agent
    Abstract: Low-MI (mechanical index) ultrasound allows real-time observation of replenishment kinetics after destruction ("flash") of ultrasound contrast agents (USCA). We developed an examination protocol and a mathematical model to quantify perfusion of liver tissue and hepatic metastases. Using a modified multivessel model, we attempted a consistent, physiological description of microbubble replenishment in liver tissue. Perfusion parameters were calculated, separately for the arterial and portal venous phase of liver perfusion, using an i.v. bolus injection of 2 x 2.4 mL SonoVue(R). The model was evaluated for 10 examinations of liver metastases using flash/low-MI imaging. In contrast to the established, exponential model, the new model consistently describes the sigmoid replenishment of USCA measured in vivo, using flash/low-MI imaging. Parameters for blood volume, blood velocity and blood flow in liver tissue and metastases can be calculated during the arterial and the portal venous phase after a CA bolus injection. The median arterial perfusion in the examined liver metastases was more than 2.5 times higher than in normal liver tissue, whereas the median perfusion during the portal venous phase was more than five times higher in the liver tissue than that in metastases. Microbubble replenishment measured with flash/low-MI US techniques can be consistently analyzed using the multivessel model, even after a bolus injection of USCA. This allows for the quantification of perfusion of liver tissue and hepatic metastases and provides promising parameters of tissue viability and tumor characterization. (C) 2004 World Federation for Ultrasound in Medicine Biology
    Type of Publication: Journal article published
    PubMed ID: 15582235
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: brain ; RECEPTOR ; CANCER ; EXPRESSION ; BLOOD ; Germany ; LUNG ; MODEL ; imaging ; lung cancer ; LUNG-CANCER ; POPULATION ; GENE ; GENE-EXPRESSION ; TISSUE ; PATIENT ; CONTRAST ; gene expression ; metastases ; PARAMETERS ; SCINTIGRAPHY ; PET ; SOMATOSTATIN ; QUANTITATIVE ASSESSMENT ; RE ; SOMATOSTATIN ANALOG ; GA-68-DOTATOC ; LOSSES ; uptake ; FDG ; viability ; DOTATOC ; EMISSION-TOMOGRAPHY ; F-18-FDG PET ; kinetic modelling ; kinetic parameters ; non-small cell lung tumours ; TC-99M DEPREOTIDE
    Abstract: Purpose: Dynamic PET studies with Ga-68-DOTATOC were performed in patients with non-small cell lung cancer (NSCLC) to assess the somatostatin receptor 2 (SSTR2) expression. Furthermore, dynamic F-18-fluorodeoxyglucose (FDG) studies were performed in the same patients to compare the SSTR2 expression with the tumour viability. Methods: The study population comprised nine patients, examined with both tracers on two different days within 1 week. Standardised uptake values (SUVs) were calculated and a two-tissue compartment model was applied to the data. Furthermore, a non-compartment model based on the fractal dimension (FD) was applied to the data. Results: The DOTATOC uptake was generally lower than the FDG uptake. Moderately enhanced DOTATOC uptake was noted in seven of the nine tumours. All kinetic parameters exceptk (4) were lower for DOTATOC than for FDG. The mean SUV was 2.018 for DOTATOC, in comparison to 5.683 for FDG. In particular,k (3) was highly variable for DOTATOC and showed an overlap with the normal lung tissue. The fractional blood volumeV (B) was relatively low for both tracers, not exceeding 0.3. The highest significant logarithmic correlation was found for the FD of the two tracers (r=0.764,p=0.017). The logarithmic correlation for SUVs was also significant (r=0.646,p=0.060), as was that forV (B) (r=0.629,p=0.069). In contrast, none of the eight metastases which were positive on FDG PET showed any DOTATOC uptake. Conclusion: The results demonstrated moderate Ga-68-DOTATOC uptake in primary NSCLC but did not provide any evidence for SSTR2 expression in metastases. This may be caused by loss of the gene expression in metastases as compared with the primary tumours
    Type of Publication: Journal article published
    PubMed ID: 16570185
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...